Table of Content

1. Executive Summary
1.1. Global Urinary Tract Infection (UTI) Treatment Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Drug Class Lifecycle Analysis
2.4. Urinary Tract Infection (UTI) Treatment Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Urinary Tract Infection (UTI) Treatment Market Outlook: Drug Class
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Class, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
3.3.3.1. Penicillin & Combinations
3.3.3.2. Quinolones
3.3.3.3. Cephalosporin
3.3.3.4. Aminoglycoside Antibiotics
3.3.3.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
3.3.3.6. Azoles and Amphotericin B
3.3.3.7. Tetracycline (Doxycycline)
3.3.3.8. Nitrofurans (Nitrofurantoin)
3.3.3.9. Others
3.4. Market Attractiveness Analysis: Drug Class
3.5. Global Urinary Tract Infection (UTI) Treatment Market Outlook: Application
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.5.3.1. Complicated Urinary Tract Infection
3.5.3.2. Uncomplicated Urinary Tract Infection
3.6. Market Attractiveness Analysis: Application
3.7. Global Urinary Tract Infection (UTI) Treatment Market Outlook: Distribution Channel
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.7.3.1. Hospital Pharmacies
3.7.3.2. Gynecology and Urology Clinics
3.7.3.3. Drug Stores
3.7.3.4. Retail Pharmacies
3.7.3.5. Online Drug Stores
3.8. Market Attractiveness Analysis: Distribution Channel
4. Global Urinary Tract Infection (UTI) Treatment Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Drug Class
5.3.3. By Application
5.3.4. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
5.5.1. Penicillin & Combinations
5.5.2. Quinolones
5.5.3. Cephalosporin
5.5.4. Aminoglycoside Antibiotics
5.5.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
5.5.6. Azoles and Amphotericin B
5.5.7. Tetracycline (Doxycycline)
5.5.8. Nitrofurans (Nitrofurantoin)
5.5.9. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.6.1. Complicated Urinary Tract Infection
5.6.2. Uncomplicated Urinary Tract Infection
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.7.1. Hospital Pharmacies
5.7.2. Gynecology and Urology Clinics
5.7.3. Drug Stores
5.7.4. Retail Pharmacies
5.7.5. Online Drug Stores
5.8. Market Attractiveness Analysis
6. Europe Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Drug Class
6.3.3. By Application
6.3.4. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
6.5.1. Penicillin & Combinations
6.5.2. Quinolones
6.5.3. Cephalosporin
6.5.4. Aminoglycoside Antibiotics
6.5.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
6.5.6. Azoles and Amphotericin B
6.5.7. Tetracycline (Doxycycline)
6.5.8. Nitrofurans (Nitrofurantoin)
6.5.9. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.6.1. Complicated Urinary Tract Infection
6.6.2. Uncomplicated Urinary Tract Infection
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.7.1. Hospital Pharmacies
6.7.2. Gynecology and Urology Clinics
6.7.3. Drug Stores
6.7.4. Retail Pharmacies
6.7.5. Online Drug Stores
6.8. Market Attractiveness Analysis
7. East Asia Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Drug Class
7.3.3. By Application
7.3.4. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
7.5.1. Penicillin & Combinations
7.5.2. Quinolones
7.5.3. Cephalosporin
7.5.4. Aminoglycoside Antibiotics
7.5.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
7.5.6. Azoles and Amphotericin B
7.5.7. Tetracycline (Doxycycline)
7.5.8. Nitrofurans (Nitrofurantoin)
7.5.9. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.6.1. Complicated Urinary Tract Infection
7.6.2. Uncomplicated Urinary Tract Infection
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.7.1. Hospital Pharmacies
7.7.2. Gynecology and Urology Clinics
7.7.3. Drug Stores
7.7.4. Retail Pharmacies
7.7.5. Online Drug Stores
7.8. Market Attractiveness Analysis
8. South Asia & Pacific Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Drug Class
8.3.3. By Application
8.3.4. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Pacific
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
8.5.1. Penicillin & Combinations
8.5.2. Quinolones
8.5.3. Cephalosporin
8.5.4. Aminoglycoside Antibiotics
8.5.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
8.5.6. Azoles and Amphotericin B
8.5.7. Tetracycline (Doxycycline)
8.5.8. Nitrofurans (Nitrofurantoin)
8.5.9. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.6.1. Complicated Urinary Tract Infection
8.6.2. Uncomplicated Urinary Tract Infection
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.7.1. Hospital Pharmacies
8.7.2. Gynecology and Urology Clinics
8.7.3. Drug Stores
8.7.4. Retail Pharmacies
8.7.5. Online Drug Stores
8.8. Market Attractiveness Analysis
9. Latin America Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Drug Class
9.3.3. By Application
9.3.4. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
9.5.1. Penicillin & Combinations
9.5.2. Quinolones
9.5.3. Cephalosporin
9.5.4. Aminoglycoside Antibiotics
9.5.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
9.5.6. Azoles and Amphotericin B
9.5.7. Tetracycline (Doxycycline)
9.5.8. Nitrofurans (Nitrofurantoin)
9.5.9. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.6.1. Complicated Urinary Tract Infection
9.6.2. Uncomplicated Urinary Tract Infection
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.7.1. Hospital Pharmacies
9.7.2. Gynecology and Urology Clinics
9.7.3. Drug Stores
9.7.4. Retail Pharmacies
9.7.5. Online Drug Stores
9.8. Market Attractiveness Analysis
10. Middle East & Africa Urinary Tract Infection (UTI) Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Drug Class
10.3.3. By Application
10.3.4. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030
10.5.1. Penicillin & Combinations
10.5.2. Quinolones
10.5.3. Cephalosporin
10.5.4. Aminoglycoside Antibiotics
10.5.5. Sulphonamides (Sulfamethoxazole, Trimethoprim)
10.5.6. Azoles and Amphotericin B
10.5.7. Tetracycline (Doxycycline)
10.5.8. Nitrofurans (Nitrofurantoin)
10.5.9. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.6.1. Complicated Urinary Tract Infection
10.6.2. Uncomplicated Urinary Tract Infection
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.7.1. Hospital Pharmacies
10.7.2. Gynecology and Urology Clinics
10.7.3. Drug Stores
10.7.4. Retail Pharmacies
10.7.5. Online Drug Stores
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Pfizer
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Bayer AG
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Almirall SA
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. GlaxoSmithKline Pharmaceuticals Ltd.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Merck & Co., Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bristol-Myers Squibb
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Shionogi & Co., Ltd
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Cipla Inc.
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations